| Novartis
Novartis
| Novartis Healthcare
| Novartis
What are the most significant cases and/or transactions that your legal team has been involved with in the last two years? We have worked on a number of significant cases...
| Novartis Farma
The legal team overseeing Novartis’ Portuguese operations plays a key role in the global drug maker’s local operations and has become increasingly vital in a changing market. The small team...
| Novartis Group - Portugal
The legal team of Novartis Group in Portugal supports both Novartis’ day-to-day operations in the market and also in other more strategic activities involving major stakeholders. What distinguishes Novartis legal...
| Novartis
‘Novartis’ in-house team should be considered for the GC Powerlist because of its key relevance for the company and the range of experts that belong to the legal department. Novartis’...
| Novartis
Novartis is a Swiss based global pharmaceutical giant and its Turkish division is part of this global network responsible for Turkish operations and subsidiaries. Ozlem Oral Mamak, country head of...
| Novartis
Led by the widely-respected group general counsel, Felix Ehrat, the Novartis legal team has greatly improved the communications, government affairs and risk-related functions, and continue to drive the team toward...
| Novartis
The Peru legal team of global pharmaceutical company Novartis ensures the business remains legally compliant and on top of ever-changing regulation in the healthcare sector in the country. The team’s...
| Novartis México
Novartis has had a major presence in Mexico for 80 years and employs over 1,600 associates, and its lauded legal and compliance departments demonstrate its strength in the country. The...
| Novartis México
In Mexico, the Novartis Group consists of Novartis Pharmaceuticals, Vision, Sandoz, Novartis Animal Health and Novartis Vaccines and Diagnostics. With this diversity of products and more than 1,700 employees to...
| Novartis Global Services Centre
Novartis Global Services Centre (NGSC) was established in Dublin in 2013, operating under the Novartis Ireland organisation, providing a range of services facilitating the smooth running of the business within...
| Novartis
Novartis is a global name in the healthcare industry, producing and marketing drugs and therapies and providing expert healthcare consulting and other services across the world. Vivian N. Osayande, head...
The recently appointed Mateeas Anne-Marie, head of legal, runs the legal department at Novartis Romania, the Romanian division of one of the largest global pharmaceutical companies. Novartis’ large range of...
| Novartis
Multinational pharmaceutical company Novartis’ business in Russia offers a full range of healthcare products that cater to the needs of society and patients. Boasting a highly diversified portfolio, the company...
| Novartis
Novartis is a large international pharmaceutical research and manufacturing company made up of Novartis Oncology, Novartis Pharmaceuticals, and the affiliated firms or Alcon and Sandoz. Novartis’s drug development programme consists...
| Novartis Healthcare Philippines
Novartis Healthcare deals with legal and compliance affairs under one roof, via a four-person team led by Monina Vierneza in her role as country head of legal and compliance and...
| Novartis Argentina
The Argentine legal department of the multinational pharmaceutical company Novartis embraces a “matrix-like” organisational structure, whereby the country legal heads of the internal divisions (Pharma, Onco, Alcon or Sandoz) report...
| Novartis
The Nigeria-based Novartis Africa cluster legal team, led by Vivian Osayande, received nominations from dozens of external clients across the continent. The wide geography in which Novartis operates – covering...
Led by group general counsel Shannon Thyme Klinger, the Novartis legal team is made up of a number of highly skilled and dynamic lawyers who expertly navigate the legal matters of the company. As the legal team behind the international Swiss multinational pharmaceutical services provider, they possess a vast and in-depth knowledge of the healthcare and pharmaceutical sector, constantly staying abreast of local regulations in this area. Fully entrusted to deal with large-scale transactions, the legal team has assisted in several pivotal transactions in the last year with the aim of enriching Novartis’ portfolio and shedding non-core assets to focus on prescription drugs. The legal function most recently assisted in Novartis’ purchase of Xiidra, a dry eye drug, from Takeda for up to $5.3bn as part of reinforcing the company’s ophthalmic medicines portfolio.